Alana McNulty is our Chief Business Officer. Ms. McNulty has served as our Chief Financial Officer from July 2012 to December 2020, and also as our Chief Business Officer since 2019. Previously, Ms. McNulty also served as Chief Financial Officer of Lumena Pharmaceuticals Inc., a biopharmaceutical company, from July 2012 until its acquisition by Shire plc in November 2014, and as Chief Financial Officer of Excaliard Pharmaceuticals, Inc., a biopharmaceutical company, from March 2011 through its acquisition by Pfizer Inc. in November 2011. Previously, Ms. McNulty was Chief Financial Officer at BrainCells, Inc., a biopharmaceutical company, from 2004 until 2011 and Chief Financial Officer of Elitra Pharmaceuticals Inc., a biopharmaceutical company, from 1998 to 2003. Prior to that Ms. McNulty was head of Corporate Development and a General Manager of a business unit at Advanced Tissue Sciences. Ms. McNulty received a B.A. in Biology with High Honors from the University of California, Santa Barbara where she graduated Phi Beta Kappa, and an M.B.A. from the Anderson School of Business at the University of California, Los Angeles.